has been cited by the following article(s):
[1]
|
Vanishing bile duct syndrome: a sequela of temozolomide and levetiracetam-induced cholestatic liver injury
BMJ Case Reports,
2024
DOI:10.1136/bcr-2024-260830
|
|
|
[2]
|
Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature
Epilepsy & Behavior Reports,
2021
DOI:10.1016/j.ebr.2021.100464
|
|
|
[3]
|
Case Report: Levetiracetam causing acute liver failure complicating post-operative management in a neurosurgical patient
F1000Research,
2019
DOI:10.12688/f1000research.18198.1
|
|
|
[4]
|
Antiepileptic Drugs and Liver Disease
Pediatric Neurology,
2017
DOI:10.1016/j.pediatrneurol.2017.09.013
|
|
|